Scgmck1, betja Brilacidin is first to partner. This drug is proving to be money in the bank, big time. J&J must be paranoid to crazy that some other company will snatch this from their grasp. This drug has so many components that fit into its product line. And it is not the only company interested. And you can bet a bidding war. Leo has said that he has an understanding agreement with a deep pocketed drug company regarding a partnership. And I believe the impending UP data will be the data that can put this over the top. That might be a little too optomistic. We just may hafta wait until OM data and more UP numbers. But Brilacidin is first to partner, IMHO.
Good luck to all longs and may all the shorts get inflamed bowels.
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links